Vallelonga, Fabrizio http://orcid.org/0000-0002-4628-6767
Di Stefano, Cristina
Merola, Aristide
Romagnolo, Alberto
Sobrero, Gabriele
Milazzo, Valeria
Burrello, Alessio
Burrello, Jacopo
Zibetti, Maurizio
Veglio, Franco
Maule, Simona
Article History
Received: 14 December 2018
Revised: 9 February 2019
Accepted: 14 February 2019
First Online: 19 February 2019
Compliance with ethical standards
:
: Fabrizio Vallelonga reports no disclosures. Cristina Di Stefano reports no disclosures. Aristide Merola is supported by NIH (KL2 TR001426) and has received speaker honoraria from CSL Behring, Abbvie, and Cynapsus Therapeutics. He has received grant support from Lundbeck and Abbvie and personal compensation from Lundbeck, Abbvie, and Abbott. Alberto Romagnolo has received grant support and speaker honoraria from AbbVie, speaker honoraria from Chiesi Farmaceutici and travel grants from Lusofarmaco and UCB Pharma. Gabriele Sobrero reports no disclosures. Valeria Milazzo reports no disclosures. Alessio Burrello reports no disclosures. Jacopo Burrello reports no disclosures. Maurizio Zibetti has received speaker’s honoraria from Medtronic, Chiesi Farmaceutici, UCB Pharma, and AbbVie. Franco Veglio reports no disclosures. Simona Maule reports no disclosures.
: The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. The local institutional review board (<i>Comitato Etico Interaziendale Città della Salute e della Scienza di Torino</i>) approved the study and all participants provided written informed consent.